Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
U
Uchegbu, Ijeoma
University College London
(
T1230-04-20
)
Mechanism of Curcumin Encapsulation by GCPQ Polymers: Unexpected Polymer Mesh (Matrix) Configuration Revealed by Atomistic Molecular Dynamics Simulations
Ijeoma Uchegbu
Favorite
Uchida, Atsushi
University of Yamanashi Hospital
(
W1030-09-50
)
Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Atsushi Uchida
Favorite
Uchida, Haruka
Meiji Pharmaceutical University
(
W1230-11-61
)
In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
Haruka Uchida
Favorite
Uchida, Shinichi
Tokyo Medical and Dental University
(
W1030-02-10
)
Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Shinichi Uchida
Favorite
Uchiyama, Hiromasa
Osaka Medical and Pharmaceutical University
(
M1230-03-15
)
Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Hiromasa Uchiyama
Favorite
(
M1530-11-65
)
Investigation of Dissolution and Permeation Properties of Amorphous Drug Particles Dispersed in Wax-Based Formulations
Hiromasa Uchiyama
Favorite
Uddin, Mohammad Nasir
Mercer University
(
T0930-03-15
)
Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study
Mohammad Nasir Uddin
Favorite
(
M0930-04-20
)
An Innovative Dual Action Antibiotic Adjuvant Strategy Using Ionic Liquid toward Synergistic Restoration of Activity in MDRO and Enhancing Antimicrobial Activity Against MRSA
Mohammad Nasir Uddin
Favorite
(
W0930-01-03
)
Optimization of Phospholipid Based Nano Drug Delivery System of Osimertinib - An In Vitro Drug Release, Ex Vivo Permeability Study
Mohammad Nasir Uddin
Favorite
Ueno, Takashi
Eisai Co. Ltd.
(
M0930-10-57
)
Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [
14
C]E7386 in Healthy Male Subjects
Takashi Ueno
Favorite
Uner, Burcu
St. Louis College of Pharmacy
(
M0930-05-27
)
Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Burcu Uner
Favorite
(
M1030-03-17
)
Bioresponsive Hydrogel Compositions Designed to Fortify Natural Contraceptive Barrier Properties of the Cervicovaginal Environment in Humans
Burcu Uner
Favorite
Usciak, Adam
ARx, LLC
(
T1030-09-52
)
Weekly Apixaban Transdermal Delivery System
Adam Usciak
Favorite
(
T1130-09-52
)
A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Adam Usciak
Favorite
Uth, Leonie-Lara Dorothea
Heinrich Heine University Düsseldorf
(
M1030-03-15
)
Formulation-Related Influences on the Ex Vivo Permeation of Lidocaine Hydrochloride Films
Leonie-Lara Dorothea Uth
Favorite
(
M1230-11-63
)
Prediction Model for the Dry Film Thickness in the Continuous Manufacturing of Oral Films
Leonie-Lara Dorothea Uth
Favorite
Uttreja, Prateek
University of Mississippi
(
M1530-07-38
)
Twin Screw Melt Granulation: Enhancing Solubility and Release Profile of Simvastatin Using Miscible and Immiscible Polymer Blends
Prateek Uttreja
Favorite
(
T1030-01-04
)
Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Prateek Uttreja
Favorite
(
T1130-07-40
)
Development of Mathematical Function Control-Based 3D Printed Tablets and Effect on Drug Release
Prateek Uttreja
Favorite
Uyeda, Craig
Amgen Inc.
(
M0930-10-58
)
Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Craig Uyeda
Favorite
